Diflucan

C₁₃H₁₂F₂N₆O306.27 g/mol

2-(2,4-Difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 3365.

Registration

Applicants: 1
Registrations: 7

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Pfizer Laboratories (Pty) Ltd2 of 7 cancelled	Diflucan	50 mg/ 5 ml, 50 mg, 100 mg, 150 mg, 200 mg, 200 mg/ 5 ml	280150, 280151, 300150, 300151, 350187, V0339, V0340	Not determined	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Diflucan capsules 100 MG EACH CAPSULE CONTAINS FLUCONAZOLE 100 mg	100 mgCapsules	28015028/20.2.2/0150	Registered	Not determined	PI PIL
Diflucan capsules 200 MG EACH CAPSULE CONTAINS FLUCONAZOLE 200 mg	200 mgCapsules	28015128/20.2.2/0151	Registered	Not determined	PI PIL
Diflucan 50 mg/ 5 ML EACH 5 ml SUSPENSION CONTAINS FLUCONAZOLE 50,0 mg	50 mg/ 5 ml	30015030/20.2.2/0150	Registered	Not determined	PI PIL
Diflucan 200 mg/ 5 ML EACH 5 ml SUSPENSION CONTAINS FLUCONAZOLE 200,0 mg	200 mg/ 5 ml	30015130/20.2.2/0151	Registered	Not determined	PI PIL
Diflucan tablets 200 MG EACH TABLET CONTAINS FLUCONAZOLE 200,0 mg	200 mgTablets	35018735/20.2.2/0187	Cancelled	Not determined	None
Diflucan capsules 50 MG EACH CAPSULE CONTAINS FLUCONAZOLE 50 mg	50 mgCapsules	V0339V/20.2.2/339	Cancelled	Not determined	PI PIL
Diflucan capsules 150 MG EACH CAPSULE CONTAINS FLUCONAZOLE 150 mg	150 mgCapsules	V0340V/20.2.2/340	Registered	Not determined	PI PIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

S4: Fluconazole
- except as a single dose of 150 mg when indicated for the following fungal infections in adults
- Vaginal candidiasis, recurrent
- Candidial balanitis associated with vaginal candidiasis. (S2)
Consolidated Schedules 06 July 2026, lines 6351 to 6355
S2: Fluconazole
- as a single dose of 150 mg when indicated for the following fungal infections in adults:
- Vaginal candidiasis, recurrent
- Candidial balanitis associated with vaginal candidiasis.
Consolidated Schedules 06 July 2026, lines 1994 to 1998

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading Wikipedia summary

SAHPRA documents

Professional information (PI)For healthcare professionalsDiflucan capsules 100 MG, Pfizer Laboratories (Pty) Ltd. SAHPRA's document for Diflucan Patient information leaflet (PIL)For patients and carersDiflucan capsules 100 MG, Pfizer Laboratories (Pty) Ltd. SAHPRA's document for Diflucan

These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles